[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575655":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":29,"responsibleParty":50,"collaborators":10,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Oregon Health and Science University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"non-COVID patients on ventilator support",null,"There is only one arm in the study, no randomization. Any non-COVID patient admitted to the ICU and requiring ventilation support will be eligible for enrollment into the study.",[13],"Other: There is no intervention in this observational study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"There is no intervention in this observational study","No direct intervention will be done to patients eligible for the study. There will be a shunt placed to divert 5-15% of exhaled breath into a collection tube. This will not affect the patient's existing standard medical care.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Laura H Nguyen, B.S.","CONTACT","503-418-4733","nguyelau@ohsu.edu",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Albert Chi, M.D., F.A.C.S","503-494-5300","chia@ohsu.edu",[30],{"facility":5,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Portland","Oregon","97239","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-122.67621,45.52345,{"lat":41,"lon":40},[44,47],{"name":45,"role":22,"phone":23,"phoneExt":10,"email":46},"Laura Nguyen, BS","traumare@ohsu.edu",{"name":48,"role":49,"phone":10,"phoneExt":10,"email":10},"Albert Chi, MD","PRINCIPAL_INVESTIGATOR",{"type":49,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Albert Chi","M.D., F.A.C.S.","100575655","exhaled-breath-a-novel-technique-for-rapid-diagnosis-of-respiratory-diseases-and-infections-100575655",false,"NCT06775106","Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections","EXB","Inclusion Criteria:\n\n* Non-COVID-19 adult consented patients (\\>18yo) on ventilatory support in the ICU at OHSU\n\nExclusion Criteria:\n\n* Patients with \"severe respiratory distress\" as defined by arterial pO2 of \\\u003C60 mmHg on maximal FiO2 \\& optimal ventilator settings\n* Patient with severe hemodynamic instability as defined by (a) receiving IV infusion of 2 or more pressors or inotropic medications (Levophed, vasopressin, phenylephrine, or epinephrine) \\& (b) MAP of \\\u003C60 mmHg or SB \\\u003C80 mmHg","ALL","18 Years","120 Years",{"count":64,"type":65},100,"ESTIMATED","OBSERVATIONAL","This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.",[69,70],"Pulmonary Disease","Critical Illness",[72,73,74,75],"ventillator","critical care","pulmonary disease","inflammatory biomarkers","2025-01-09",{"date":78,"type":79},"2025-01-14","ACTUAL",{"date":81,"type":79},"2024-11-30",{"date":83,"type":65},"2026-12-31",{"name":5,"class":6},1]